Melanasa

Hydroquinone, the active ingredient in Melanasa, is a skin depigmenting agent presented as a topical preparation for skin application. It works to reduce excess melanin formation and is employed in the management of hyperpigmentation conditions such as melasma, age spots, and post‑inflammatory discoloration in adult patients.

GNH USA supplies Melanasa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melanasa is a topical skin depigmenting agent used to address disorders of melanin overproduction. It is indicated for the following conditions: - Melasma: helps lighten brown patches on the face and improve overall skin tone. - Age spots: reduces the appearance of solar lentigines and other age‑related pigmentations. - Post‑inflammatory hyperpigmentation: diminishes dark spots that develop after skin injury or inflammation.

Hydroquinone may cause a range of skin reactions, from mild irritation to rare but serious events.

Common Side Effects: - Skin irritation: mild redness or burning at the application site. - Dryness: increased skin dryness or flaking. - Itching: localized pruritus. - Peeling: superficial desquamation of treated skin. - Contact dermatitis: eczema‑like rash. - Increased photosensitivity: heightened reaction to sunlight.

Serious or Rare Side Effects: - Exogenous ochronosis: permanent darkening of the skin with prolonged use. - Severe allergic reaction: swelling, hives, or difficulty breathing. - Persistent hyperpigmentation: paradoxical darkening of treated areas. - Secondary infection: bacterial infection of compromised skin. - Scarring: rare development of permanent skin marks. - Systemic absorption effects: unlikely but reported in extensive application over large body surface.

When using Melanasa, consider the following safety measures: - Sun exposure: avoid direct sunlight and use broad‑spectrum sunscreen. - Application area: do not apply to broken, inflamed, or infected skin. - Duration of use: limit continuous treatment to the period recommended by a healthcare professional. - Concomitant products: avoid using other bleaching or irritating skin products simultaneously. - Monitoring: discontinue if severe irritation or allergic signs develop. - Store at room temperature: keep in the original container, protect from moisture and direct light.

Hydroquinone can interact with other topical agents, affecting tolerability or efficacy.

Major Interactions (Avoid): - Combined use with other depigmenting agents (e.g., tretinoin, corticosteroids) may increase irritation risk. - Application over chemical peels or laser-treated skin can cause severe burns. - Use with strong acids (glycolic, salicylic) may exacerbate skin damage.

Moderate Interactions (Monitor Closely): - Concurrent use of sunscreen enhances safety and effectiveness. - Mild irritants (e.g., fragrance‑rich moisturizers) may require monitoring for additive irritation. - Use with systemic photosensitizing drugs warrants caution and sun protection. - Co‑administration with other topical antioxidants generally safe but observe for unexpected reactions.